Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity.
about
Lipid biology of breast cancerAn unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMSDifferential detection of tumor cells using a combination of cell rolling, multivalent binding, and multiple antibodies.Lipotoxicity in the heart.An RNA interference screen identifies metabolic regulators NR1D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signature.Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cellsFatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.Exposure to lard-based high-fat diet during fetal and lactation periods modifies breast cancer susceptibility in adulthood in rats.Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cellsThe potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathwaysAcid ceramidase as a therapeutic target in metastatic prostate cancer.PPARγ maintains ERBB2-positive breast cancer stem cells.PPARG is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetProteomics revisits the cancer metabolome.Berberine hydrochloride: anticancer activity and nanoparticulate delivery system.Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies.The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells.Metabolic Assays for Detection of Neutral Fat Stores.Implication of atypical supraclavicular F18-fluorodeoxyglucose uptake in patients with breast cancer: Association between brown adipose tissue and breast cancer.Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis.Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor.Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells.Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis
P2860
Q27013858-E8E65B97-66CF-4963-8161-C016DEF81164Q27334982-3C82CDB1-3147-4D98-8811-EBEC2DF241BDQ30581258-B056D5EE-6A81-4A45-86A1-93CF58E03226Q33665107-134A3BFA-B6AD-4451-BE39-520DC9BECDD3Q33722873-E6DBB985-BAA9-4115-B0B7-342A5E8D46B0Q34365660-70951D56-7E45-4AB1-AD22-3716B7E4F506Q34613543-2E08A18E-66EA-4B2A-95CD-8615C63B4235Q35688497-FB4AA8D5-FC34-452C-A448-30E4D29F0ED3Q35849265-7E98B52F-629C-4D09-A337-189EF9303D39Q36087653-72E3048D-20C9-4D4C-B8EB-2D95745642B4Q36355817-1FE4233B-D03E-40A5-9306-2AEC4BDBAAB7Q36754783-1CD934E0-8AF0-45B8-8AF4-94FD8F2A350AQ37501777-7110FCC1-892C-4C67-B150-B0B8590BD916Q37734001-119E4682-DBEA-4DAE-AFDF-D9C945147B4DQ37912205-0F885253-BE95-4A38-9E39-476CAF90F3F4Q37935557-18BFE848-9960-4B60-AC96-7E67D9A9669DQ38063484-83C834E3-95BE-4293-84D8-BD439BF2901CQ38071479-42457564-7D08-4748-AD73-1D270355D0DAQ39251611-390E1E70-F1DC-42ED-95D4-5D6D6691BAD6Q39609137-E69CA517-67DF-41FF-B1F5-30A29C4C7EE1Q41846641-ADFAA5E8-44D5-4156-AA9C-7B2680C97AD4Q42051009-FA5539FC-3793-4D25-BB27-DBC5362A028DQ49996449-0112355D-36D0-45D3-807D-A9262A623A06Q52883022-07C6F9A6-37DB-43AB-9F9D-1A6D81605C37Q53076500-871FF696-9380-4AD3-9B6F-DCB6940B06CFQ55284992-923C1653-F5EC-48D8-B7D9-FF407C54474EQ57817278-585BD344-552B-4535-BE40-BD69FF83A4F2
P2860
Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... cells from palmitate toxicity.
@en
Peroxisome proliferator-activa ...... cells from palmitate toxicity.
@nl
type
label
Peroxisome proliferator-activa ...... cells from palmitate toxicity.
@en
Peroxisome proliferator-activa ...... cells from palmitate toxicity.
@nl
prefLabel
Peroxisome proliferator-activa ...... cells from palmitate toxicity.
@en
Peroxisome proliferator-activa ...... cells from palmitate toxicity.
@nl
P2093
P2860
P356
P1476
Peroxisome proliferator-activa ...... cells from palmitate toxicity
@en
P2093
M Julia Brosnan
Rekha Srinivasaiah
Richard D Carkner
P2860
P2888
P356
10.1186/BCR2240
P577
2009-03-19T00:00:00Z
P5875
P6179
1046479867